{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T21:00:29Z","timestamp":1758056429028,"version":"3.44.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,15]]},"DOI":"10.7759\/cureus.92377","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T15:37:48Z","timestamp":1757950668000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical and Molecular Profiles and Treatment Outcomes in Patients With Acute Promyelocytic Leukaemia: A Single-Centre Experience"],"prefix":"10.7759","author":[{"given":"Omkar   K","family":"Choudhari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Soni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lalit M","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Disha","family":"Satya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satyajeet","family":"Soni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveen","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hemant","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dr. Purvish  M","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(02)00626-8","article-title":"The role of PML in tumour suppression","volume":"108","author":"Salomoni P","year":"2002","unstructured":"Salomoni P, Pandolfi PP. The role of PML in tumour suppression. Cell. 2002, 108:165-70. 10.1016\/s0092-8674(02)00626-8","journal-title":"Cell"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.6004\/jadpro.2018.9.2.4","article-title":"Acute promyelocytic leukemia: a summary","volume":"10","author":"Ryan MM","year":"2018","unstructured":"Ryan MM. Acute promyelocytic leukemia: a summary. J Adv Pract Oncol. 2018, 10:6004. 10.6004\/jadpro.2018.9.2.4","journal-title":"J Adv Pract Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15133477","article-title":"The coagulopathy of acute promyelocytic leukemia: an updated review of pathophysiology, risk stratification, and clinical management","volume":"15","author":"Hermsen J","year":"2023","unstructured":"Hermsen J, Hambley B. The coagulopathy of acute promyelocytic leukemia: an updated review of pathophysiology, risk stratification, and clinical management. Cancers (Basel). 2023, 15:3477. 10.3390\/cancers15133477","journal-title":"Cancers (Basel)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1757303","article-title":"Complications during induction chemotherapy in acute promyelocytic leukemia: an institutional experience","volume":"12","author":"Yedla RP","year":"2023","unstructured":"Yedla RP, Bala SC, Pydi VR, Chennamaneni R, Kuruva SP, Konatam ML, Gundeti S. Complications during induction chemotherapy in acute promyelocytic leukemia: an institutional experience. South Asian J Cancer. 2023, 12:274-9. 10.1055\/s-0042-1757303","journal-title":"South Asian J Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0219-5","article-title":"Molecular remission as a therapeutic objective in acute promyelocytic leukemia","volume":"32","author":"Cicconi L","year":"2018","unstructured":"Cicconi L, Fenaux P, Kantarjian H, Tallman M, Sanz MA, Lo-Coco F. Molecular remission as a therapeutic objective in acute promyelocytic leukemia. Leukemia. 2018, 32:1671-8. 10.1038\/s41375-018-0219-5","journal-title":"Leukemia"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.htct.2024.05.002","article-title":"Diagnosis and management of acute promyelocytic leukemia: Brazilian consensus guidelines 2024 on behalf of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy","volume":"46","author":"de Figueiredo-Pontes LL","year":"2024","unstructured":"de Figueiredo-Pontes LL, Catto LF, Chauffaille ML, et al.. Diagnosis and management of acute promyelocytic leukemia: Brazilian consensus guidelines 2024 on behalf of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy. Hematol Transfus Cell Ther. 2024, 46:553-69. 10.1016\/j.htct.2024.05.002","journal-title":"Hematol Transfus Cell Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.03096","article-title":"Arsenic combined with all-trans retinoic acid for pediatric acute promyelocytic leukemia: report from the CCLG-APL2016 protocol study","volume":"39","author":"Zheng H","year":"2021","unstructured":"Zheng H, Jiang H, Hu S, et al.. Arsenic combined with all-trans retinoic acid for pediatric acute promyelocytic leukemia: report from the CCLG-APL2016 protocol study. J Clin Oncol. 2021, 39:3161-70. 10.1200\/JCO.20.03096","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V130.Suppl_1.4869.4869.","article-title":"A normal prothrombin time, activated partial thromboplastin time and fibrinogen level do not eliminate disseminated intravascular coagulation (DIC) and bleeding risk in patients with acute promyelocytic leukemia","volume":"130","author":"Simon KS","year":"2017","unstructured":"Simon KS, Kharkhanis P, Caprara CR, et al.. A normal prothrombin time, activated partial thromboplastin time and fibrinogen level do not eliminate disseminated intravascular coagulation (DIC) and bleeding risk in patients with acute promyelocytic leukemia. Blood. 2017, 130:4869. 10.1182\/blood.V130.Suppl_1.4869.4869.","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/896394","article-title":"Early death in two patients with acute promyelocytic leukemia presenting the bcr3 isoform, FLT3-ITD mutation, and elevated WT1 level","volume":"2013","author":"Greco M","year":"2013","unstructured":"Greco M, Caocci G, Ledda A, Vacca A, Arras M, Celeghini I, La Nasa G. Early death in two patients with acute promyelocytic leukemia presenting the bcr3 isoform, FLT3-ITD mutation, and elevated WT1 level. Case Rep Hematol. 2013, 2013:896394. 10.1155\/2013\/896394","journal-title":"Case Rep Hematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2019.08.006","article-title":"Prognostic significance of bcr-1 and bcr-3 isoforms of PML-RARA and FLT3-ITD in patients with acute promyelocytic leukemia","volume":"20","author":"Rasekh EO","year":"2020","unstructured":"Rasekh EO, Elsayed GM, Madney Y, El Gammal MM. Prognostic significance of bcr-1 and bcr-3 isoforms of PML-RARA and FLT3-ITD in patients with acute promyelocytic leukemia. Clin Lymphoma Myeloma Leuk. 2020, 20:156-67. 10.1016\/j.clml.2019.08.006","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2012.11.024","article-title":"Thrombosis in acute promyelocytic leukemia","volume":"131","author":"Rashidi A","year":"2013","unstructured":"Rashidi A, Silverberg ML, Conkling PR, Fisher SI. Thrombosis in acute promyelocytic leukemia. Thromb Res. 2013, 131:281-9. 10.1016\/j.thromres.2012.11.024","journal-title":"Thromb Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1055\/a-2238-4782","article-title":"Thrombosis in acute promyelocytic leukemia: the current understanding","author":"Sabljic N","year":"2024","unstructured":"Sabljic N, Mitrovic M, Pantic N, Thachil J. Thrombosis in acute promyelocytic leukemia: the current understanding. Hamostaseologie. 2024, 10.1055\/a-2238-4782","journal-title":"Hamostaseologie"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2014.11.026","article-title":"Thrombotic events in acute promyelocytic leukemia","volume":"135","author":"Mitrovic M","year":"2015","unstructured":"Mitrovic M, Suvajdzic N, Elezovic I, et al.. Thrombotic events in acute promyelocytic leukemia. Thromb Res. 2015, 135:588-93. 10.1016\/j.thromres.2014.11.026","journal-title":"Thromb Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-158017\/v1","article-title":"Risk factors of thrombosis in Chinese subjects with acute promyelocytic leukemia","volume":"19","author":"Zhang X","year":"2021","unstructured":"Zhang X, Guo X. Risk factors of thrombosis in Chinese subjects with acute promyelocytic leukemia. Thromb J. 2021, 19:42. 10.21203\/rs.3.rs-158017\/v1","journal-title":"Thromb J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.9.3093.","article-title":"The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia","volume":"91","author":"Barbui T","year":"1998","unstructured":"Barbui T, Finazzi G, Falanga A. The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia. Blood. 1998, 91:3093-102. 10.1182\/blood.V91.9.3093.","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2011.068","article-title":"Pathogenesis and treatment of thrombohemorrhagic diathesis in acute promyelocytic leukemia","volume":"3","author":"Falanga A","year":"2011","unstructured":"Falanga A, Russo L, Tartari CJ. Pathogenesis and treatment of thrombohemorrhagic diathesis in acute promyelocytic leukemia. Mediterr J Hematol Infect Dis. 2011, 3:e2011068. 10.4084\/MJHID.2011.068","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.14744\/ejmo.2017.87597","article-title":"Testicular and cutaneous relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy","volume":"1","author":"Erkek ET","year":"2017","unstructured":"Erkek ET, Demir N, Ozkan G, et al.. Testicular and cutaneous relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Eur J Med Oncol. 2017, 1:53-4. 10.14744\/ejmo.2017.87597","journal-title":"Eur J Med Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.049007","article-title":"Clinical impact of FLT3 mutation load in acute promyelocytic leukemia with t(15;17)\/PML-RARA","volume":"96","author":"Schnittger S","year":"2011","unstructured":"Schnittger S, Bacher U, Haferlach C, Kern W, Alpermann T, Haferlach T. Clinical impact of FLT3 mutation load in acute promyelocytic leukemia with t(15;17)\/PML-RARA. Haematologica. 2011, 96:1799-807. 10.3324\/haematol.2011.049007","journal-title":"Haematologica"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergen.2018.12.003","article-title":"Influence of bcr-3 PML-RAR\u03b1 transcript on outcome in acute promyelocytic leukemia patients of Kashmir treated with all-trans retinoic acid and\/or arsenic tri-oxide","author":"Baba SM","year":"2019","unstructured":"Baba SM, Shah ZA, Pandith AA, et al.. Influence of bcr-3 PML-RAR\u03b1 transcript on outcome in acute promyelocytic leukemia patients of Kashmir treated with all-trans retinoic acid and\/or arsenic tri-oxide. Cancer Genet. 2019, 231-2:14-21. 10.1016\/j.cancergen.2018.12.003","journal-title":"Cancer Genet"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.095380","article-title":"FLT3-ITD confers poor prognosis in patients with acute promyelocytic leukemia treated with AIDA protocols: long-term follow-up analysis","volume":"98","author":"Breccia M","year":"2013","unstructured":"Breccia M, Loglisci G, Loglisci MG, et al.. FLT3-ITD confers poor prognosis in patients with acute promyelocytic leukemia treated with AIDA protocols: long-term follow-up analysis. Haematologica. 2013, 98:e161-3. 10.3324\/haematol.2013.095380","journal-title":"Haematologica"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2019.12.011","article-title":"Outcomes in adult acute promyelocytic leukemia: a decade experience","volume":"20","author":"Yedla RP","year":"2020","unstructured":"Yedla RP, Bala SC, Pydi VR, et al.. Outcomes in adult acute promyelocytic leukemia: a decade experience. Clin Lymphoma Myeloma Leuk. 2020, 20:e158-64. 10.1016\/j.clml.2019.12.011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4103\/0019-509X.84938","article-title":"Acute promyelocytic leukemia: an experience from a tertiary care centre in north India","volume":"48","author":"Bajpai J","year":"2011","unstructured":"Bajpai J, Sharma A, Kumar L, Dabkara D, Raina V, Kochupillai V, Kumar R. Acute promyelocytic leukemia: an experience from a tertiary care centre in north India. Indian J Cancer. 2011, 48:316-22. 10.4103\/0019-509X.84938","journal-title":"Indian J Cancer"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-05-718114","article-title":"The role of leukocytes in thrombosis","volume":"128","author":"Swystun LL","year":"2016","unstructured":"Swystun LL, Liaw PC. The role of leukocytes in thrombosis. Blood. 2016, 128:753-62. 10.1182\/blood-2016-05-718114","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/411281-clinical-and-molecular-profiles-and-treatment-outcomes-in-patients-with-acute-promyelocytic-leukaemia-a-single-centre-experience","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T15:37:49Z","timestamp":1757950669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/411281-clinical-and-molecular-profiles-and-treatment-outcomes-in-patients-with-acute-promyelocytic-leukaemia-a-single-centre-experience"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.92377","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,15]]}}}